Saturday, January 17, 2026
  • Who’sWho Africa AWARDS
  • About TimeAfrica Magazine
  • Contact Us
Time Africa Magazine
  • Home
  • Magazine
  • WHO’SWHO AWARDS
  • News
  • World News
    • US
    • UAE
    • Europe
    • UK
    • Israel-Hamas
    • Russia-Ukraine
  • Politics
  • Crime
  • Lifestyle
  • Sports
  • Column
  • Interviews
  • Special Report
No Result
View All Result
Time Africa Magazine
  • Home
  • Magazine
  • WHO’SWHO AWARDS
  • News
  • World News
    • US
    • UAE
    • Europe
    • UK
    • Israel-Hamas
    • Russia-Ukraine
  • Politics
  • Crime
  • Lifestyle
  • Sports
  • Column
  • Interviews
  • Special Report
No Result
View All Result
Time Africa Magazine
No Result
View All Result
  • Home
  • WHO’SWHO AWARDS
  • News
  • Magazine
  • World News

Home » Featured » Prof. Chinedum Babalola’s leading pharmacogenetics in Nigeria

Prof. Chinedum Babalola’s leading pharmacogenetics in Nigeria

December 25, 2022
in Featured, Interviews
0
Share on FacebookShare on Twitter

Pharmacogenetics –understanding how a person’s genes responds to medicines – is not very popular, but Prof. Chinedum Babalola, first woman pharmacist to become a vice chancellor in Nigeria, says this is important and is leading research in this field in Nigeria.

Prof. Chinedum Babalola became the vice-chancellor of Chrisland University, Nigeria in 2017 and became Nigeria’s first female pharmacist professor to occupy this position. She has a long list of “firsts” in her life story.

In 2017, she was the only Black and African out of the nine scientists and social scientists of the strategy working group of the joint committee of the International Council for Science and International Social Science Council.

In her efforts to promote health in Africa through research, and pharmacogenetics she talks about how young women researchers can succeed. Excerpts

ReadAlso

Thousands evicted from Nigeria’s ‘Venice’ as Lagos demolitions continue

Nyash, Abeg, Biko, Amala, Other Nigerian Words Added to the Oxford Dictionary

What are your research interests and the areas of pharmacy you have covered?

ADVERTISEMENT

My research is focused on several aspects of medicines including pharmacokinetics — how drugs get absorbed in the body, move to other parts of the body, and eventually get removed from the body through excretion.

I also study actions of medicines in the body, and pharmaceutical analysis, which involves identifying chemical substances, removing impurities from them, determining the quantities and determining their molecular structures.

I am involved in studying bioethics, and how one’s genes influence how medicines work — pharmacogenetics.

I was involved in a collaborative study at the University of Ile-Ife, where we examined poor metabolisers and fast metaboliser of an antimalarial called proguanil in Nigerians. We found that about four per cent of Nigerians were poor metabolisers.

My study has discovered significant drug to drug interactions between antimalarials and antibiotics that results in considerable reductions in antibiotic levels requiring dose adjustment.

My colleagues and I published a pharmacogenetic study on health in Nigeria. It means that we can carry out genetic tests and tell people that with a gene they have, they would not process a drug very well. It was a great discovery.

You have had many firsts and are the now the first female pharmacist to become a vice chancellor in Nigeria. How did your journey begin?

I was born to parents who are teachers — Isaac Anyabuike, a doctor and the late Adeline Anyabuike. I am the first of five children, four females and one male. I had a lot of responsibilities.

My parents believed in education. My mom was a disciplinarian to the core. She gave me a strong mathematics foundation that I needed for science while I was in secondary school. I became a science student and then fell in love with pharmacy.

I obtained a bachelor of pharmacy from Obafemi Awolowo University, Ife, Nigeria in 1983. I later obtained a master’s in pharmaceutical chemistry in 1987 and a doctorate in pharmaceutical chemistry in 1997 at the same institution. I embarked on a postdoctoral fellowship at the University of British Columbia, Vancouver, Canada in 1995.

I started my academic career early. I was one of the few retained to continue a career in academics after my doctorate degree at the Obafemi Awolowo University. I began my career as a graduate assistant, and rose to become a senior lecturer.

I rose through the ranks both at Obafemi Awolowo University, Ife and at the University of Ibadan, Nigeria, to become a professor in 2006, a first for a female pharmacist in this institution. From then on, I have continued to be the first in so many instances.

Tell us about your scientific achievements

As a principal investigator, we won a MacArthur Foundation US$1 million grant to set up a Centre of Excellence – Centre for Drug Discovery Development and Production (CDDDP) in 2012. CDDDP was set up to empower Africans to make and regulate their medicines. The Centre has built capacity in Nigeria and has up to six new pharmaceutical products awaiting approval.

The main thing we have done is to bridge the gap between academic institutions, medicine, and drug development. Today, we have three anti-COVID products.

What advice do you have for young female professionals?

I have been mentoring several female professionals. I encourage them to persevere in the face of adversity to succeed.

If you intend to marry, take your time and choose a man who will support you. If I did not have a supportive husband, I would not be able to achieve these things. I encourage young women to collaborate with those better than themselves in research to learn from them how to apply for grants. Go ahead and apply for grants. Don’t give up if you fail. With determination and God on your side, you will make it.

This interview has been edited for clarity and brevity.

Tags: Chinedum BabalolaChrisland UniversityNigeriaPharmacogenetics
ADVERTISEMENT
Previous Post

China stops publishing daily Covid figures amid reports of explosion in cases

Next Post

Pope Francis, Archbishop of Canterbury call for end to war in Ukraine

You MayAlso Like

Column

Seventh term, 76 years old, 40 years in power: is there an end to Museveni’s rule?

January 17, 2026
Column

How climate crisis is creating hellish conditions for waste pickers at Nairobi dump declared ‘full’ 24 years ago

January 12, 2026
Column

ETF 2026:  Inside Enugu’s Race to Become Africa’s Tech Mecca

January 11, 2026
Featured

Bill Gates warns the world is going ‘backwards’ and gives 5-year deadline before we enter a new Dark Age

January 10, 2026
Column

Pastor Chris Okafor’s Contrition That Merit Forgiveness (Eum Condonatum Est)

January 3, 2026
Featured

Africa 2025–2026: A Continent of Contrasts, Challenges and Hope

January 1, 2026
Next Post

Pope Francis, Archbishop of Canterbury call for end to war in Ukraine

Rodrigo De Paul is named as the most handsome player at the World Cup in Qatar 2022

Discussion about this post

Thousands evicted from Nigeria’s ‘Venice’ as Lagos demolitions continue

His Imperial Majesty Obi Dr Greg Oputa III hails Oborevwori on performance

Trump proposes tariffs on countries that oppose his plans for Greenland

Uganda’s President Yoweri Museveni wins seventh term with 71.65% of votes

Africa 2025–2026: A Continent of Contrasts, Challenges and Hope

Morocco’s AFCON performance energises plans to host World Cup 2030

  • Thousands evicted from Nigeria’s ‘Venice’ as Lagos demolitions continue

    543 shares
    Share 217 Tweet 136
  • His Imperial Majesty Obi Dr Greg Oputa III hails Oborevwori on performance

    542 shares
    Share 217 Tweet 136
  • Trump proposes tariffs on countries that oppose his plans for Greenland

    541 shares
    Share 216 Tweet 135
  • Uganda’s President Yoweri Museveni wins seventh term with 71.65% of votes

    541 shares
    Share 216 Tweet 135
  • Africa 2025–2026: A Continent of Contrasts, Challenges and Hope

    551 shares
    Share 220 Tweet 138
  • Trending
  • Comments
  • Latest

Thousands evicted from Nigeria’s ‘Venice’ as Lagos demolitions continue

January 17, 2026

His Imperial Majesty Obi Dr Greg Oputa III hails Oborevwori on performance

January 17, 2026

Trump proposes tariffs on countries that oppose his plans for Greenland

January 17, 2026

Uganda’s President Yoweri Museveni wins seventh term with 71.65% of votes

January 17, 2026

Dozens of people killed in torrential rains and floods across southern Africa

January 17, 2026

Seventh term, 76 years old, 40 years in power: is there an end to Museveni’s rule?

January 17, 2026

Uganda’s President Yoweri Museveni wins seventh term with 71.65% of votes

January 17, 2026

US accuses South Africa military of ‘cosying up to Iran’

January 17, 2026

ABOUT US

Time Africa Magazine

TIMEAFRICA MAGAZINE is an African Magazine with a culture of excellence; a magazine without peer. Nearly a third of its readers hold advanced degrees and include novelists, … READ MORE >>

SECTIONS

  • Aviation
  • Column
  • Crime
  • Europe
  • Featured
  • Gallery
  • Health
  • Interviews
  • Israel-Hamas
  • Lifestyle
  • Magazine
  • Middle-East
  • News
  • Politics
  • Press Release
  • Russia-Ukraine
  • Science
  • Special Report
  • Sports
  • TV/Radio
  • UAE
  • UK
  • US
  • World News

Useful Links

  • AllAfrica
  • Channel Africa
  • El Khabar
  • The Guardian
  • Cairo Live
  • Le Republicain
  • Magazine: 9771144975608
  • Subscribe to TIMEAFRICA MAGAZINE biweekly news magazine

    Enjoy handpicked stories from around African continent,
    delivered anywhere in the world

    Subscribe

    • About TimeAfrica Magazine
    • Privacy Policy
    • Contact Us
    • WHO’SWHO AWARDS

    © Copyright TimeAfrica Magazine Limited 2026 - All rights reserved.

    No Result
    View All Result
    • WHO’SWHO AWARDS
    • Politics
    • Column
    • Interviews
    • Gallery
    • Lifestyle
    • Special Report
    • Sports
    • TV/Radio
    • Aviation
    • Health
    • Science
    • World News

    © Copyright TimeAfrica Magazine Limited 2026 - All rights reserved.

    This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.